Need a specific person's email?
Browse Xenetic Biosciences, Inc.'s employee directory (about 7 employees) and reveal verified emails free.
Xenetic Biosciences, Inc.'s most common email format is F.Last@xeneticbio.com (ex. J.Doe@xeneticbio.com), used for 74% of xeneticbio.com addresses. Xenetic Biosciences, Inc. uses 4 email patterns.
| Format | Example | Share of xeneticbio.com |
|---|---|---|
| F.Last@xeneticbio.comMost common | J.Doe@xeneticbio.com | |
| First.Last@xeneticbio.com | John.Doe@xeneticbio.com | |
| L.First@xeneticbio.com | D.John@xeneticbio.com | |
| FirstLast@xeneticbio.com | JohnDoe@xeneticbio.com |
Browse Xenetic Biosciences, Inc.'s employee directory (about 7 employees) and reveal verified emails free.
Biotechnology ResearchMassachusetts, United States2-10 Employees
Xenetic Biosciences, Inc., based in Framingham, Massachusetts, operates in the biotechnology research sector focusing on cancer therapies. Its XCART program is a personalized CAR T platform designed to target patient-specific tumor neoantigens, with initial work aimed at B-cell lymphomas by focusing on the B-cell receptor on malignant cells. The company also develops PolyXen, a proprietary drug-delivery technology, and holds an exclusive Takeda license in coagulation disorders with royalty potential. Xenetic pursues collaborations to advance its DNase oncology program, including partnerships with The Scripps Research Institute and with Tokyo Medical University. A recent development is the acceptance of an abstract for presentation at the 2026 ASCO Annual Meeting in Chicago.
Most common format
F.Last@xeneticbio.com
Example: J.Doe@xeneticbio.com
Free with a LeadIQ account. No credit card.
Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.